Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 13, 2007

View Archived Issues

Carfilzomib well tolerated in consecutive-day schedule in hematologic malignancies

New preclinical and clinical data detail antithrombotic effects of YM-150

Novo Nordisk reports results for the third quarter 2007

Preclinical studies of anti-DKK1 mAb show potential for multiple myeloma therapy

Pooled trial data confirm eculizumab efficacy in paroxysmal nocturnal hemoglobinuria

Rivaroxaban thromboprophylaxis effective after hip replacement surgery

Bv8 promotes tumor growth through angiogenesis

New therapeutic agents for neurological disorders reported in recent patents

BioLineRx enters license agreement with Innovative Pharmaceutical Concepts for BL-5010

BioCancell reports successful experimental treatment using BC-819 for ovarian cancer

BioInvent designates BI-505 for blood cancer as new drug candidate

Astion Pharma initiates phase III clinical studies of ASF-1057 for seborrheic dermatitis

FDA grants approval to Resverlogix to initiate phase Ia clinical trial of RVX-208

Recent AstraZeneca and Argenta patents impart new therapeutic agents for respiratory disorders

Novel guanylate cyclase activators imparted in recent Bayer patent

ImmunoVaccine Technologies to acquire Immunotope

Mutant MOR gene transfer plus naloxone treatment leads to analgesia without tolerance in mice

Targacept initiates phase I clinical trial of TC-6499 for neuropathic pain

AVANIR initiates enrollment in phase III trial of Zenvia for pseudobulbar affect

Dia-B Tech reports positive results from phase I clinical study of ISF-402 for type 2 diabetes

Cobalamin oral insulin significantly reduces glucose in preclinical study

FDA grants orphan drug designation to GTC Biotherapeutics' ATryn

Wyeth Pharmaceuticals initiates phase I/II clinical trial of Trubion's TRU-015 for NHL

Celsion refiles for an FDA Special Protocol Assessment for phase III trial of ThermoDox

Medarex and Bristol-Myers report positive results from three registrational trials of ipilimumab

FDA grants approval to SKCC for phase I clinical trial of breast cancer vaccine

FDA advisory committee recommends approval of Kynapid for acute atrial fibrillation

Ono and Banyu submit Japanese approval application for sitagliptin for type 2 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...